Tesla: Q1 Consensus Estimates

Tesla (NASDAQ: TSLA) will be reporting their first quarter financial results on April 26th after market close. Analysts have a consensus $650.81 12-month price target on the company, via a total of 38 analysts, with nine analysts having strong buy ratings. Six analysts meanwhile have buy ratings, 12 have hold ratings, seven analysts have a sell rating and four have strong sells on the company. The street high comes from Piper Sandler with a $1,200 price target, and the lowest target sits at $67 from GLJ Research.

21 analysts have revenue estimates for the first quarter. The mean revenue estimate between all 21 analysts is $10.62 billion; this number has been revised upwards from $10.3 billion at the start of the year. The highest revenue estimate is $12.34 billion, while the lowest is $8.2 billion.

Onto EBITDA estimates, there are currently only 8 analysts who have first-quarter EBITDA estimates. The mean is currently $1.8 billion, with this number having been revised down from $2 billion at the start of the year. The street high estimate currently sits at $2 billion in EBITDA and the lowest is $1.2 billion.

Analysts estimate that quarterly earnings per share will come in at $0.85, with this number being slightly revised down from $0.91 at the start of the year. Street high is $0.97 and the lowest estimate is $0.46 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Roscan Gold: Mali Discount Hits Kandiole PEA

Recommended

Questcorp Launches Phase 2 Exploration Program At La Union To Follow Up On 20.2 g/t Gold Over 30 Metre Chip-Channel Sample

First Majestic Boosts Silver Reserves 16% As Exploration Outpaces Production

Related News

Ascend Wellness: Canaccord Initiates With US$15 Price Target

Canaccord Genuity is the first investment bank to initiate coverage on Ascend Wellness (CSE: AAWH.u)....

Tuesday, May 25, 2021, 03:12:00 PM

Tesla: FinTwits’ Analysis On The Q4 2023 Financials

Tesla (NASDAQ: TSLA) last night released its financial results for the fourth quarter of 2023,...

Thursday, January 25, 2024, 10:08:48 AM

Aurora Cannabis: Stifel Lowers Rating To Hold, Price Target Falls To $10.50 From $16

Yesterday, Aurora Cannabis (TSX: ACB) (NYSE: ACB) provided a business update. The firm announced that...

Wednesday, September 9, 2020, 01:47:00 PM

Ayr Wellness Sees Canaccord Cut Target To $30 Following Q2 Miss

On August 18, Ayr Wellness (CSE: AYR.A)s reported its second quarter financial results. The company...

Sunday, September 4, 2022, 03:01:00 PM

Teslagate: 100GB Tesla Files Leaked To Media By Disgruntled Ex-Employee, Showed Thousands Of Autopilot Complaints

Struggling with Autopilot, employees’ and customers’ private information, and trade secrets–these are some of the...

Friday, May 26, 2023, 11:29:00 AM